MyChesCo on MSN2h
Mineralys Therapeutics Completes Enrollment for Explore-CKD Phase 2 Trial
Mineralys Therapeutics, Inc. (Nasdaq: MLYS) has announced the completion of enrollment for its Explore-CKD Phase 2 trial. The ...
Healio6h
SGLT2 inhibitor plus calorie restriction improves diabetes remission rate
Use of a sodium-glucose cotransporter 2, or SGLT2, inhibitor combined with calorie restriction resulted in greater rates of type 2 diabetes remission compared with calorie restriction alone, according ...
Health Rounds: Ingested plastic particles head for the brain
The tiny bits of plastic pollution that make their way from the environment into our bodies accumulate at much higher ...
Medindia9h
Diabetes Health Center
Trusted source of information on diabetes that includes articles, news, videos, animations, quizzes, calculators and drugs.
Knowridge10h
New diabetes drug may protect kidneys and lungs better, study finds
A recent study from the University of Hong Kong suggests that a newer type of diabetes drug, called sodium-glucose cotransporter 2 inhibitors (SGLT2i), may help protect the kidneys and lungs in people ...
News Medical17h
Scientists design strategy for preventing cardiotoxic effects of anthracyclines
A team of scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC), working in collaboration with international partners, has designed a strategy for preventing the cardiotoxic ...